19.0% Above Target

CBNA's consensus price target is $32, -19.0% below the current price of $39.49. The 2 analysts tracking CBNA see downside risk at present valuations.

CBNA has a consensus rating of "Hold" based on 2 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $32 implies -19.0% downside from current levels.

With a forward P/E of 8.408x, CBNA trades at a relatively low valuation. The consensus target of $32 implies -19.0% move, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $37 for CBNA, while the most conservative target is $27. The consensus of $32 represents the median expectation. Our quantitative valuation model projects a bull case target of $57 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CBNA is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CBNA stock forecast based on 2 Wall Street analysts shows a consensus price target of $32, with estimates ranging from $27 (bear case) to $37 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $43, with bear/bull scenarios of $27/$57.

Our quantitative valuation model calculates CBNA's fair value at $43 (base case), with a bear case of $27 and bull case of $57. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.

CBNA trades at a forward P/E ratio of 8.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on CBNA, with 0 Sell ratings and a price target of $32 (-19.0% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CBNA analyst price targets range from $27 to $37, a 31% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $32 consensus represents the middle ground. Our model's $27-$57 range provides an independent fundamental perspective.